tm logo
BP BALKAN PHARMACEUTICALS
Live/Registered
REGISTERED

on 06 Oct 2020

Last Applicant/ Owned by

Serial Number

79272941 filed on 01st Oct 2019

Registration Number

6166331 registered on 06th Oct 2020

in the Principal Register

Correspondent Address

Bruce S. Londa

Norris McLaughlin P.A.

7 Times Square

New York NY 10036-6524

Filing Basis

No Filing Basis

Disclaimer

"BALKAN PHARMACEUTICALS"

BP BALKAN PHARMACEUTICALS

Blue: all the verbal and figurative elements; white: background "BALKAN PHARMACEUTICALS" The mark consists of the letters "BP" with a vertical curved band between the letters, all in blue, to the left of a blue double helix design. Below the letters and design is the wording "BALKAN PHARMACEUTICALS" in blue letters. All on a white background. Pharmaceutical, medical and veterinary products, namRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical, medical and veterinary products, namely, products for treating digestive maladies and for affecting metabolism namely, antacids, antiulcerous preparations, antiflatulence preparations; antispastics, anticolinergics, antipropulsives; antivomitive and antinauseants, antidiarrheals; digestive aids, namely, food enzyme and dietary supplements; metabolic aids, namely, stanozolol, methandienone, mesterolone, oxandrolone and nandrolone; products for treating the liver, namely, lipotropics; products for treating disorders and illnesses of blood, haematopoetic organs- and the heparin group, namely, platelet antiaggregants; products for treating disorders and illnesses of the cardiovascular system and for providing heart therapy, namely, diuretics, peripherical vasodilators; blockers, namely, bisoprolol, pantoprazole, famotidine and naltrexone; products that act on the renin-angiotensin system, namely, ramipril, lizinopril, enalapril and captoprile; pharmaceuticals, namely, lipid lowering agents; genital-urinary system and sexual hormones, sexual and modulator hormones of the genital system, genital system medications; systemic hormonal preparations; antiinfectious products for systemic use, namely, ofloxacine, metronidazole, acyclovir, amoxaciline and furaciline; antineoplastic agents and immunomodulators; products for treating the skeletal muscle system, namely, antiinflammatory and antirheumatic non-steroids; products for treating the nervous system, namely, anesthetics, anticonvulsants, antiemetics, antiparkinson agents, CNS stimulants, muscle relaxants, narcotic analgesics, nonnarcotic analgesics, and sedatives; antiparasitics; products for treating the breathing pathway, namely, antiasthmatics, systemic antihistamines; sanitary products for medical use, namely, absorbent products for personal health care and hygiene, medical disinfectant liquids, wipes, sprays and soaps

Mark Details


Serial Number

No 79272941

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 125086-3

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.29 -

Helixes

26.17.09 -

Curved line(s), band(s) or bar(s)

Description of Design Search

The mark consists of the letters "BP" with a vertical curved band between the letters, all in blue, to the left of a blue double helix design. Below the letters and design is the wording "BALKAN PHARMACEUTICALS" in blue letters. All on a white background.

Legal History


Show more

Status DateAction Taken
01st Mar 2021FINAL DECISION TRANSACTION PROCESSED BY IB
28th Jan 2021GENERIC MADRID TRANSACTION SENT TO IB
28th Jan 2021GENERIC MADRID TRANSACTION CREATED
06th Jan 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06th Oct 2020REGISTERED-PRINCIPAL REGISTER
31st Jul 2020NOTIFICATION PROCESSED BY IB
21st Jul 2020PUBLISHED FOR OPPOSITION
21st Jul 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15th Jul 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
15th Jul 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB